These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 17223774)
1. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction? Bailey LJ; Naganathan V Med J Aust; 2007 Jan; 186(2):99-100; author reply 100-101. PubMed ID: 17223774 [No Abstract] [Full Text] [Related]
2. Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care? Scheiner MA; Kimmel SE J Gen Intern Med; 1997 Sep; 12(9):581-2. PubMed ID: 9294792 [No Abstract] [Full Text] [Related]
3. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants. Michaels AD; Maynard C; Every NR; Barron HV Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326 [TBL] [Abstract][Full Text] [Related]
4. Specialized heart failure centers--a success or an indicator of the failure of our health care delivery system. Pitt B; Nicklas JM Clin Cardiol; 2000 Dec; 23(12):881-2. PubMed ID: 11129672 [No Abstract] [Full Text] [Related]
5. [Differential therapy of heart failure. Which drug for which patient?]. Schillinger W; Hermann HP; Hasenfuss G Internist (Berl); 2004 Dec; 45(12):1378-87. PubMed ID: 15526078 [TBL] [Abstract][Full Text] [Related]
6. Management of patients with acute myocardial infarction and end-stage renal disease. Conti CR J Am Coll Cardiol; 2003 Jul; 42(2):209-10. PubMed ID: 12875752 [No Abstract] [Full Text] [Related]
7. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners? Houghton AR; Cowley AJ Int J Cardiol; 1997 Mar; 59(1):7-10. PubMed ID: 9080020 [TBL] [Abstract][Full Text] [Related]
9. Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction. LeJemtel TH; Hochman JS; Sonnenblick EH J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):47S-51S. PubMed ID: 7775715 [TBL] [Abstract][Full Text] [Related]
10. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939 [TBL] [Abstract][Full Text] [Related]
11. Patterns of prescribing ACE inhibitors after myocardial infarction. Luzier AB; Navsarikar A; Wilson MF; Ashai K; Forrest A Pharmacotherapy; 1999 May; 19(5):655-60. PubMed ID: 10331830 [TBL] [Abstract][Full Text] [Related]
12. Prescribing pattern of angiotensin- converting enzyme inhibitors and beta blockers after acute myocardial infarction. Sweileh WM; Shkokani FM; Sawalha AF; Al-Ramahi RJ; Jaradat NA; Zaid AA; Barakat AS Saudi Med J; 2005 Nov; 26(11):1837-9. PubMed ID: 16311686 [No Abstract] [Full Text] [Related]
13. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. Berger AK; Duval S; Krumholz HM J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751 [TBL] [Abstract][Full Text] [Related]
14. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Barron HV; Michaels AD; Maynard C; Every NR J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461 [TBL] [Abstract][Full Text] [Related]
17. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction. Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577 [TBL] [Abstract][Full Text] [Related]
19. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction? A multicentre study. Krum H; Meehan A; Varigos J; Loane PR; Billah B Med J Aust; 2006 Aug; 185(4):191-4. PubMed ID: 16922662 [TBL] [Abstract][Full Text] [Related]
20. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice. Cheng TO Cardiology; 1996; 87(3):267. PubMed ID: 8801029 [No Abstract] [Full Text] [Related] [Next] [New Search]